Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...
Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.
In a new report from the American Cancer Society, mortality rates for prostate cancer are two times higher for Black men compared to White men. A new report from the American Cancer Society (ACS) ...
Prostate cancer incidence is increasing, especially in advanced stages, reversing previous declines and slowing mortality rate improvements. Racial disparities persist, with Black and Native American ...
Today, the American Cancer Society (ACS) released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States. According to the study, prostate ...
News-Medical.Net on MSN
Cancer mortality drops 34% as treatments and early detection improve
The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...
Hosted on MSN
Prostate cancer statistics reveal late-stage incidence rates continue to increase rapidly as mortality declines slow
The American Cancer Society (ACS) has released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States. According to the study, prostate ...
Following almost a decade of decline, prostate cancer incidence in the U.S. increased 3.0% per year between 2014 through 2021, according to a report published Sept. 2 in CA: A Cancer Journal for ...
Prostate cancer diagnoses increased by 3% per year from 2014 to 2021, with the sharpest increase seen in advanced-stage disease. Prostate cancer mortality rates have continued to decline, but at a ...
Prostate cancer deaths in the United States were on the decline, thanks to advances in screening and treatment but new data from the American Cancer Society (ACS) shows that the tide is shifting — ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback